tositumomab (Bexxar)

Introduction

Tradename: Bexxar (FDA approved 2003)

Indications

• refractory non-Hodgkin's lymphoma

Mechanism of action

• radiolabeled monoclonal antibody against CD20

More general terms

• antineoplastic monoclonal antibody

Component of

• iodine/tositumomab